PrintThe Burrill Report (November 6, 2009): A Sequencing Revolution Ushers in a New Era (.MP3,9.38 Mb)
Complete Genomics is helping to usher in a new era of biomedical research with breakthrough technology for low-cost genome sequencing that promises to help researchers unlock the genetic mysteries underlying diseases. The Mountain View, California-based company recently announced that the Institute for Systems Biology will work with it to sequence 100 genomes in a study of Huntington’s disease, an effort that will represent the largest human genome disease association study to date. We spoke to Cliff Reid, CEO of Complete Genomics about the project, how low-cost sequencing technology promises to revolutionize biomedical research, and his company’s ambitious vision.
.gif)
.gif)
